YOLFTbeta
CU Medical Systems Inc

CU Medical Systems Inc

115480 · KQ · Healthcare / Healthcare Equipment & Supplies

1,984.00KRW-4.00 (-0.20%)

Price History

Full chart

Market Stats

Previous Close1,988.00
Open2,075.00
Day Range1,983.00 – 2,075.00
52-Week Range1,624.00 – 3,310.00
Volume3.58K
Market Cap27.59B
P/E (TTM)0.00
Forward P/E0.00
Dividend Yield0.00%
Beta0.68
50-Day Avg2,139.02
200-Day Avg2,434.50

About

CU Medical Systems, Inc. manufactures and sells defibrillators worldwide. The company offers automatic external defibrillators (AEDs), mechanical cardiopulmonary resuscitation systems, healthcare and rehabilitation products, AED trainers, and sterilizers/disinfectors. It also resells Apple products, including Mac, iPad, and iPod. The company was founded in 2001 and is headquartered in Wonju-si, South Korea.

Company Details

  • SectorHealthcare
  • IndustryHealthcare Equipment & Supplies
  • CEOShin-Hee Kang
  • Employees119
  • Headquarters130-1, Dongwhagongdan-ro, Wonju-si, South Korea, Korea
  • Websitehttps://www.cu911.com

Leadership

  • Shin-Hee KangManaging Director · b. 1971
  • Soo-Rang LeeManaging Director · b. 1963
  • Hyung-Soo KimChief Exec. Officer

Financials

Income Statement

Currency: KRW2012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue21.64B23.67B24.70B25.68B54.58B58.35B76.30B81.79B28.32B35.40B46.96B41.80B40.63B48.22B
Growth (%)-+9.37%+4.34%+3.97%+112.52%+6.91%+30.78%+7.20%-65.38%+25.01%+32.64%-10.98%-2.81%+18.69%
Cost of Revenue10.98B12.85B12.62B13.75B42.99B45.82B59.31B63.95B15.83B16.93B22.26B21.40B19.08B19.71B
Gross Profit--10.94B11.93B11.59B12.53B16.99B17.84B12.49B18.48B24.70B20.40B21.55B28.51B
Gross Margin--44.28%46.45%21.23%21.47%22.27%21.81%44.10%52.19%52.60%48.81%53.03%59.13%
Operating Expense--11.40B10.96B12.80B15.30B13.22B15.73B22.53B20.19B14.20B18.12B14.40B17.44B
Operating Income2.60B58.37M-463.29M971.89M-1.21B-2.77B3.77B2.11B-10.04B-1.71B10.50B2.29B7.15B11.07B
Operating Margin12.00%0.25%-1.88%3.78%-2.22%-4.75%4.94%2.58%-35.46%-4.84%22.35%5.47%17.60%22.96%
EBITDA----------12.55B-5.18B1.33B6.25B
EBITDA Margin----------26.73%-12.40%3.28%12.96%
Net Income2.18B184.94M-3.53B1.68B-1.56B-3.15B1.75B-2.91B-25.74B-13.98B9.43B-8.20B-3.20B819.20M
Net Income Margin10.07%0.78%-14.31%6.55%-2.86%-5.40%2.29%-3.56%-90.89%-39.49%20.07%-19.62%-7.89%1.70%
R&D-3.33B3.11B1.13B1.18B1.28B1.41B1.29B1.35B1.84B2.62B2.91B2.19B2.47B
R&D as % of Total Revenue-14.07%12.59%4.39%2.15%2.20%1.85%1.57%4.78%5.21%5.59%6.97%5.38%5.11%
Interest Expense000000003.14B1.14B454.24M325.57M1.15B1.45B
Interest Expense % of Total Revenue0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%11.07%3.21%0.97%0.78%2.82%3.00%

Balance Sheet

Currency: KRW2012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets44.93B64.25B61.05B66.72B63.54B61.66B104.87B129.28B81.66B72.84B88.08B85.65B103.57B99.66B
Total Liabilities9.54B23.95B24.89B28.85B21.99B19.59B57.40B78.86B39.80B23.95B29.72B31.43B44.83B39.99B
Total Equity35.39B37.71B33.90B37.86B41.55B42.08B47.47B50.42B41.86B48.89B58.36B53.74B58.74B59.68B
Cash2.97B10.06B2.74B8.50B4.67B6.93B5.41B9.20B3.01B985.00K1.58M9.87B1.77M18.56B
Total Debt---22.93B14.92B12.51B27.62B30.90B12.37B-----
Net Debt--------22.82B1.66B12.05B12.82B22.32B13.74B

Cash Flow

Currency: KRW2012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow--551.48M3.51B-230.09M6.96B3.12B-5.12B8.41B490.43M3.12B8.28B14.07B9.69B
Investing Cash Flow---4.96B-2.04B-3.81B-2.98B-41.25B-9.52B-24.03B-1.52B-13.97B-11.48B-31.87B-
Financing Cash Flow1.63B16.19B-2.62B4.18B382.43M-1.49B36.34B18.05B13.76B10.24B5.30B7.04B21.08B-
Capital Expenditure422.38M2.32B970.94M1.19B1.56B38.27M36.56B826.85M1.28B5.19B11.60B6.47B20.06B776.17M
Free Cash Flow--------6.18B-4.89B-8.48B1.80B-5.99B8.91B
FCF to OCF--------73.39%-996.91%-271.78%21.79%-42.57%91.99%

Earnings

Report DateMay 30, 2012Aug 29, 2012Nov 28, 2012Feb 27, 2013May 29, 2013Aug 28, 2013Nov 27, 2013Feb 26, 2014May 28, 2014Sep 3, 2014Dec 3, 2014Feb 25, 2015Jun 3, 2015Sep 2, 2015Dec 2, 2015Mar 2, 2016Jun 1, 2016Aug 17, 2016Nov 16, 2016Feb 17, 2017May 16, 2017Aug 14, 2017Nov 14, 2017Mar 16, 2018May 15, 2018Aug 14, 2018Nov 14, 2018Mar 7, 2019May 15, 2019Aug 14, 2019Nov 13, 2019May 13, 2020Aug 12, 2020Nov 11, 2020May 17, 2021Aug 17, 2021Nov 17, 2021May 17, 2022Aug 16, 2022Nov 14, 2022Mar 1, 2023May 15, 2023Aug 15, 2023Nov 14, 2023May 13, 2024Aug 14, 2024Nov 14, 2024Feb 26, 2025Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026
EPS Estimate-----------------------------------------------------
EPS Actual223.32436.34-216.52441.6679.01-6.12-282.44233.7080.44-195.25-344.80-730.29246.46-30.16-44.50393.16-8.84-58.24-18.42-24.0221.9812.47-28.87-181.7711.977.874.1473.68-12.07-23.77355.28-335.353.95-535.27137.11-97.74-0.04343.09388.31515.64-249.74240.35-210.6477.37145.8667.24-43.24-482.7551.6949.64160.75-194.41203.04
Surprise-----------------------------------------------------
Timing-----------------Pre-marketAfter-hoursPre-marketAfter-hoursPre-marketPre-marketAfter-hoursPre-marketPre-marketPre-marketPre-marketAfter-hoursPre-market-----------------------

Key Statistics & Ratios

Market Cap27.59B
Enterprise Value43.37B
Trailing P/E0.00
Forward P/E0.00
Price / Sales0.62
Price / Book0.39
Revenue (TTM)45.05B
Gross Profit (TTM)18.42B
EBITDA12.64B
Profit Margin-6.48%
Operating Margin23.94%
Return on Equity-692.78%
Return on Assets7.80%
Shares Outstanding15.89M
Shares Float41.71M
Beta0.68
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Stock Splits

  • May 20, 20261:5
  • Jun 24, 2021806:707
  • Apr 12, 20162:1